Latest brain cancer Stories
Voices Against Brain Cancer (VABC) responds to an article posted by Cancer Research UK detailing key cancer research New York, NY (PRWEB) April 26, 2013 On April 26, Voices Against Brain Cancer (VABC) responds to an article posted by Cancer Research UK detailing how researchers may have discovered a new tactic that will help predict whether or not cases of breast cancer will spread to the brain. The Cancer Research UK article states that a team of researchers based at Baylor College of...
Voices Against Brain Cancer (VABC), the organization dedicated to brain cancer research and advocacy, responds to an article published on biosciencetechnology.com that examines a Phase 2 clinical trial study focusing on a new brain cancer treatment. New York, NY (PRWEB) April 22, 2013 On April 22, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, comments on an article published by Biosciencetechnology.com that discusses a new Phase 2...
Unprecedented Results Compared With Current Standard of Care BETHESDA, Md., April 18, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today that Brad Silver, an All American swimming and water polo athlete who was diagnosed with Glioblastoma multiforme (GBM) brain cancer in late 2002, and was treated with DCVax-L in March of 2003, just celebrated the...
Trial Sites Will Receive Support from UK Health System BETHESDA, Md., April 16, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today that the Company's Phase III clinical trial for Glioblastoma multiforme (GBM) brain cancer has been "adopted" as a national priority trial in the UK, under the "adoption" program managed by the National Institute for...
Following an article about brain cancer patient Iram Leon winning the Gusher Marathon, Voices Against Brain Cancer (VABC) issues a statement. New York, NY (PRWEB) April 15, 2013 On April 15, 2013, Voices Against Brain Cancer commends Iram Leon following a Beaumont Enterprise article discussing Leon's win at a marathon while pushing his 6-year-old daughter Kiana in a stroller. The Beaumont Enterprise article stated that Iram Leon won the Gusher marathon in 3 hours, 7 minutes, and 35...
VANCOUVER, British Columbia and MENLO PARK, Calif., April 10, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor. The data are being presented at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C. during a clinical poster session entitled,...
Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain may be a contributing factor to the development of brain tumors. Bohemia, NY (PRWEB) April 05, 2013 On April 5, 2013, Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain could be a contributing factor in the development of brain tumors. The...
Voices Against Brain Cancer (VABC) applauds the efforts of 6th-grader Andrew Bauer, who helped raise awareness about brain cancer in his school, and encouraged teachers and classmates to wear gray in support of fighting the disease. New York, NY (PRWEB) April 01, 2013 On April 1, 2013, Voices Against Brain Cancer applauds the actions of 6th-grader Andrew Bauer, who helped raise awareness of brain cancer in Long Valley Middle School. Bauer encouraged classmates and teachers to wear gray in...
VANCOUVER, British Columbia and MENLO PARK, Calif., April 1, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "A Phase I/II study of VAL-083 in patients with recurrent malignant glioma or secondary brain tumor" at the American Association of Cancer Research (AACR) Annual Meeting, which is being held April 6 - 10, 2013 in Washington D.C., USA. DelMar will present new clinical data from its...
VABC, the organization dedicated to brain cancer research and advocacy, responds to an article published in Forbes on a Danish study that found no correlation between cell phone use and brain cancer. New York, NY (PRWEB) March 27, 2013 On March 27, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, reacts to a recent Danish study’s findings which indicate that there’s no link between cell phone use and brain cancer. According to...
